文献速递神经肿瘤

1型神经纤维瘤病成人胶质瘤的临床、组织学和分子特征

Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1.
PubMed 文献 · Neuro Oncol · 2023-01-01

该回顾性研究纳入1990至2020年在三家中心就诊的45例1型神经纤维瘤病(NF1)成人非视路胶质瘤患者,中位年龄37岁,71%肿瘤位于中线且仅行活检。所有检测的27例肿瘤均为IDH1野生型,中位总生存期24个月,1-2级胶质瘤为38.5个月,提示低级别肿瘤也可呈侵袭性病程。

要点

  • NF1成人非视路胶质瘤中71%位于中线且仅行活检。
  • 所有检测的27例肿瘤均为IDH1野生型,与组织学无关。
  • 中位总生存期24个月,1-2级胶质瘤为38.5个月。

核心结论

  • NF1成人非视路胶质瘤(包括低级别肿瘤)常呈侵袭性临床病程,提示需更好地理解这些NF1相关胶质瘤的病理生物学。

研究设计与样本

  • 回顾性研究纳入1990至2020年在约翰霍普金斯医院、纪念斯隆凯特琳癌症中心和华盛顿大学就诊的45例NF1成人(≥18岁)组织学确诊的非视路胶质瘤患者,并进行中心病理复核。

主要发现

  • 45例患者中女性23例(51%),中位年龄37岁(范围18-68岁),体能状态80%(范围30%-100%)。
  • 35例患者有组织可用,诊断包括弥漫性(低级别)星形细胞瘤9例、胶质母细胞瘤7例、伴毛样特征的高级别星形细胞瘤4例、毛细胞型星形细胞瘤4例、高级别星形细胞瘤3例、未达到WHO诊断4例,以及胶质肉瘤、神经节胶质瘤、胚胎性肿瘤和弥漫性中线胶质瘤各1例。
  • 71%的肿瘤位于中线且仅行活检。
  • 所有检测的27例肿瘤均为IDH1野生型,与组织学无关。
  • 10例进行分子检测的病例中,最常见遗传变异为NF1、EGFR、ATRX、CDKN2A/B、TP53、TERT和MSH2/3突变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: People with NF1 have an increased prevalence of central nervous system malignancy. However, little is known about the clinical course or pathologic features of NF1-associated gliomas in adults, limiting clinical care and research. METHODS: Adults (≥18 years) with NF1 and histologically confirmed non-optic pathway gliomas (non-OPGs) at Johns Hopkins Hospital, Memorial Sloan Kettering Cancer Center, and Washington University presenting between 1990 and 2020 were identified. Retrospective data were collated, and pathology was reviewed centrally. RESULTS: Forty-five patients, comprising 23 females (51%), met eligibility criteria, with a median of age 37 (18-68 years) and performance status of 80% (30%-100%). Tissue was available for 35 patients. Diagnoses included infiltrating (low-grade) astrocytoma (9), glioblastoma (7), high-grade astrocytoma with piloid features (4), pilocytic astrocytoma (4), high-grade astrocytoma (3), WHO diagnosis not reached (4) and one each of gliosarcoma, ganglioglioma, embryonal tumor, and diffuse midline glioma. Seventy-one percent of tumors were midline and underwent biopsy only. All 27 tumors evaluated were IDH1-wild-type, independent of histology. In the 10 cases with molecular testing, the most common genetic variants were NF1, EGFR, ATRX, CDKN2A/B, TP53, TERT, and MSH2/3 mutation. While the treatments provided varied, the median overall survival was 24 months [2-267 months] across all ages, and 38.5 [18-109] months in individuals with grade 1-2 gliomas. CONCLUSIONS: Non-OPGs in adults with NF1, including low-grade tumors, often have an aggressive clinical course, indicating a need to better understand the pathobiology of these NF1-associated gliomas.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Romo CG, Piotrowski AF, Campian JL, et al. Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1. Neuro Oncol. 2023. PMID: 36840626. doi:10.1093/neuonc/noad033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。